Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage
We conducted a post hoc analysis to assess the potential impact of GAP (gender, age, physiology) stage on the treatment effect of nintedanib in patients with idiopathic pulmonary fibrosis. Outcomes were compared in patients at GAP stage I versus II/III at baseline in the INPULSIS® trials. At baselin...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2019-04-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/5/2/00127-2018.full |